ID   KPB1_HUMAN              Reviewed;        1223 AA.
AC   P46020; B7ZL05; B7ZL07; Q2M3D7;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2006, sequence version 2.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform;
DE            Short=Phosphorylase kinase alpha M subunit;
GN   Name=PHKA1; Synonyms=PHKA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Muscle;
RX   PubMed=8226841;
RA   Wuellrich A., Hamacher C., Schneider A., Kilimann M.W.;
RT   "The multiphosphorylation domain of the phosphorylase kinase alpha M
RT   and alpha L subunits is a hotspot of differential mRNA processing and
RT   of molecular evolution.";
RL   J. Biol. Chem. 268:23208-23214(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-735, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-972 AND SER-985, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-758; SER-972 AND
RP   SER-985, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729; SER-972; SER-981
RP   AND SER-985, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   VARIANT GSD9D VAL-299.
RX   PubMed=12825073; DOI=10.1038/sj.ejhg.5200996;
RA   Burwinkel B., Hu B., Schroers A., Clemens P.R., Moses S.W., Shin Y.S.,
RA   Pongratz D., Vorgerd M., Kilimann M.W.;
RT   "Muscle glycogenosis with low phosphorylase kinase activity: mutations
RT   in PHKA1, PHKG1 or six other candidate genes explain only a minority
RT   of cases.";
RL   Eur. J. Hum. Genet. 11:516-526(2003).
CC   -!- FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of
CC       serine in certain substrates, including troponin I. The alpha
CC       chain may bind calmodulin.
CC   -!- ENZYME REGULATION: By phosphorylation of various serine residues.
CC       Allosteric regulation by calcium.
CC   -!- PATHWAY: Glycan biosynthesis; glycogen metabolism.
CC   -!- SUBUNIT: Hexadecamer of 4 heterotetramers, each composed of alpha,
CC       beta, gamma, and delta subunits. Alpha (PHKA1 or PHKA2) and beta
CC       (PHKB) are regulatory subunits, gamma (PHKG1 or PHKG2) is the
CC       catalytic subunit, and delta is calmodulin.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}; Cytoplasmic side {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=AC;
CC         IsoId=P46020-1; Sequence=Displayed;
CC       Name=2; Synonyms=C;
CC         IsoId=P46020-2; Sequence=VSP_004697;
CC       Name=3;
CC         IsoId=P46020-3; Sequence=VSP_042517, VSP_042518;
CC   -!- TISSUE SPECIFICITY: Muscle specific. Isoform 1 is predominant in
CC       vastus lateralis muscle. Isoform 2 predominates slightly in heart,
CC       and it predominates clearly in the other tissues tested.
CC   -!- PTM: Although the final Cys may be farnesylated, the terminal
CC       tripeptide is probably not removed, and the C-terminus is not
CC       methylated. {ECO:0000250|UniProtKB:P18688}.
CC   -!- DISEASE: Glycogen storage disease 9D (GSD9D) [MIM:300559]: A
CC       metabolic disorder characterized by slowly progressive,
CC       predominantly distal muscle weakness and atrophy. Clinical
CC       features include exercise intolerance with early fatigability,
CC       pain, cramps and occasionally myoglobinuria.
CC       {ECO:0000269|PubMed:12825073}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the phosphorylase b kinase regulatory chain
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X73874; CAA52083.1; -; mRNA.
DR   EMBL; BX295541; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX295542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC104944; AAI04945.1; -; mRNA.
DR   EMBL; BC143499; AAI43500.1; -; mRNA.
DR   EMBL; BC143501; AAI43502.1; -; mRNA.
DR   CCDS; CCDS14421.1; -. [P46020-1]
DR   CCDS; CCDS48137.1; -. [P46020-2]
DR   CCDS; CCDS55453.1; -. [P46020-3]
DR   PIR; I38111; I38111.
DR   RefSeq; NP_001116142.1; NM_001122670.1. [P46020-2]
DR   RefSeq; NP_001165907.1; NM_001172436.1. [P46020-3]
DR   RefSeq; NP_002628.2; NM_002637.3. [P46020-1]
DR   UniGene; Hs.201379; -.
DR   ProteinModelPortal; P46020; -.
DR   BioGrid; 111273; 12.
DR   IntAct; P46020; 3.
DR   STRING; 9606.ENSP00000362643; -.
DR   ChEMBL; CHEMBL2111324; -.
DR   iPTMnet; P46020; -.
DR   PhosphoSitePlus; P46020; -.
DR   BioMuta; PHKA1; -.
DR   DMDM; 110282976; -.
DR   EPD; P46020; -.
DR   MaxQB; P46020; -.
DR   PaxDb; P46020; -.
DR   PeptideAtlas; P46020; -.
DR   PRIDE; P46020; -.
DR   TopDownProteomics; P46020-2; -. [P46020-2]
DR   DNASU; 5255; -.
DR   Ensembl; ENST00000339490; ENSP00000342469; ENSG00000067177. [P46020-2]
DR   Ensembl; ENST00000373542; ENSP00000362643; ENSG00000067177. [P46020-1]
DR   Ensembl; ENST00000541944; ENSP00000441251; ENSG00000067177. [P46020-3]
DR   GeneID; 5255; -.
DR   KEGG; hsa:5255; -.
DR   UCSC; uc004eax.5; human. [P46020-1]
DR   CTD; 5255; -.
DR   DisGeNET; 5255; -.
DR   GeneCards; PHKA1; -.
DR   GeneReviews; PHKA1; -.
DR   HGNC; HGNC:8925; PHKA1.
DR   HPA; HPA001081; -.
DR   MalaCards; PHKA1; -.
DR   MIM; 300559; phenotype.
DR   MIM; 311870; gene.
DR   neXtProt; NX_P46020; -.
DR   OpenTargets; ENSG00000067177; -.
DR   Orphanet; 715; Glycogen storage disease due to muscle phosphorylase kinase deficiency.
DR   PharmGKB; PA33266; -.
DR   eggNOG; KOG3635; Eukaryota.
DR   eggNOG; ENOG410XPJZ; LUCA.
DR   GeneTree; ENSGT00520000055553; -.
DR   HOGENOM; HOG000231478; -.
DR   HOVERGEN; HBG000273; -.
DR   InParanoid; P46020; -.
DR   KO; K07190; -.
DR   PhylomeDB; P46020; -.
DR   TreeFam; TF313970; -.
DR   BioCyc; MetaCyc:HS00901-MONOMER; -.
DR   BRENDA; 2.7.11.19; 2681.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   SIGNOR; P46020; -.
DR   UniPathway; UPA00163; -.
DR   ChiTaRS; PHKA1; human.
DR   GeneWiki; Phosphorylase_kinase,_alpha_1; -.
DR   GenomeRNAi; 5255; -.
DR   PRO; PR:P46020; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000067177; -.
DR   CleanEx; HS_PHKA1; -.
DR   ExpressionAtlas; P46020; baseline and differential.
DR   Genevisible; P46020; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005964; C:phosphorylase kinase complex; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004689; F:phosphorylase kinase activity; TAS:ProtInc.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0005980; P:glycogen catabolic process; TAS:Reactome.
DR   GO; GO:0005977; P:glycogen metabolic process; TAS:ProtInc.
DR   InterPro; IPR008928; 6-hairpin_glycosidase-like.
DR   InterPro; IPR011613; Glyco_hydro_15/PHK.
DR   InterPro; IPR008734; PHK_A/B_su.
DR   PANTHER; PTHR10749; PTHR10749; 1.
DR   Pfam; PF00723; Glyco_hydro_15; 1.
DR   SUPFAM; SSF48208; SSF48208; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; Carbohydrate metabolism;
KW   Cell membrane; Complete proteome; Disease mutation;
KW   Glycogen metabolism; Glycogen storage disease; Lipoprotein; Membrane;
KW   Muscle protein; Phosphoprotein; Prenylation; Reference proteome.
FT   CHAIN         1   1223       Phosphorylase b kinase regulatory subunit
FT                                alpha, skeletal muscle isoform.
FT                                /FTId=PRO_0000057726.
FT   REGION      810    840       Calmodulin-binding. {ECO:0000255}.
FT   REGION     1046   1086       Calmodulin-binding. {ECO:0000255}.
FT   MOD_RES     629    629       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64649}.
FT   MOD_RES     729    729       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     735    735       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     758    758       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     972    972       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     981    981       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     985    985       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1007   1007       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES    1018   1018       Phosphoserine; by PKA. {ECO:0000250}.
FT   MOD_RES    1020   1020       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18688}.
FT   MOD_RES    1023   1023       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18688}.
FT   MOD_RES    1113   1113       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64649}.
FT   LIPID      1220   1220       S-farnesyl cysteine.
FT                                {ECO:0000250|UniProtKB:P18688}.
FT   VAR_SEQ     654    713       ARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQ
FT                                TTCDLMSLVTKAKELHVQN -> D (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042517.
FT   VAR_SEQ    1011   1023       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042518.
FT   VAR_SEQ    1012   1024       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8226841}.
FT                                /FTId=VSP_004697.
FT   VARIANT     299    299       D -> V (in GSD9D; dbSNP:rs137852547).
FT                                {ECO:0000269|PubMed:12825073}.
FT                                /FTId=VAR_020856.
FT   CONFLICT    568    568       H -> Y (in Ref. 1; CAA52083).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1223 AA;  137312 MW;  48511719C0BFE40F CRC64;
     MRSRSNSGVR LDGYARLVQQ TILCHQNPVT GLLPASYDQK DAWVRDNVYS ILAVWGLGLA
     YRKNADRDED KAKAYELEQS VVKLMRGLLH CMIRQVDKVE SFKYSQSTKD SLHAKYNTKT
     CATVVGDDQW GHLQLDATSV YLLFLAQMTA SGLHIIHSLD EVNFIQNLVF YIEAAYKTAD
     FGIWERGDKT NQGISELNAS SVGMAKAALE ALDELDLFGV KGGPQSVIHV LADEVQHCQS
     ILNSLLPRAS TSKEVDASLL SVVSFPAFAV EDSQLVELTK QEIITKLQGR YGCCRFLRDG
     YKTPKEDPNR LYYEPAELKL FENIECEWPL FWTYFILDGV FSGNAEQVQE YKEALEAVLI
     KGKNGVPLLP ELYSVPPDRV DEEYQNPHTV DRVPMGKLPH MWGQSLYILG SLMAEGFLAP
     GEIDPLNRRF STVPKPDVVV QVSILAETEE IKTILKDKGI YVETIAEVYP IRVQPARILS
     HIYSSLGCNN RMKLSGRPYR HMGVLGTSKL YDIRKTIFTF TPQFIDQQQF YLALDNKMIV
     EMLRTDLSYL CSRWRMTGQP TITFPISHSM LDEDGTSLNS SILAALRKMQ DGYFGGARVQ
     TGKLSEFLTT SCCTHLSFMD PGPEGKLYSE DYDDNYDYLE SGNWMNDYDS TSHARCGDEV
     ARYLDHLLAH TAPHPKLAPT SQKGGLDRFQ AAVQTTCDLM SLVTKAKELH VQNVHMYLPT
     KLFQASRPSF NLLDSPHPRQ ENQVPSVRVE IHLPRDQSGE VDFKALVLQL KETSSLQEQA
     DILYMLYTMK GPDWNTELYN ERSATVRELL TELYGKVGEI RHWGLIRYIS GILRKKVEAL
     DEACTDLLSH QKHLTVGLPP EPREKTISAP LPYEALTQLI DEASEGDMSI SILTQEIMVY
     LAMYMRTQPG LFAEMFRLRI GLIIQVMATE LAHSLRCSAE EATEGLMNLS PSAMKNLLHH
     ILSGKEFGVE RSVRPTDSNV SPAISIHEIG AVGATKTERT GIMQLKSEIK QVEFRRLSIS
     AESQSPGTSM TPSSGSFPSA YDQQSSKDSR QGQWQRRRRL DGALNRVPVG FYQKVWKVLQ
     KCHGLSVEGF VLPSSTTREM TPGEIKFSVH VESVLNRVPQ PEYRQLLVEA ILVLTMLADI
     EIHSIGSIIA VEKIVHIAND LFLQEQKTLG ADDTMLAKDP ASGICTLLYD SAPSGRFGTM
     TYLSKAAATY VQEFLPHSIC AMQ
//
